Pathogenicity of GB virus C on virus hepatitis and hemodialysis patients

Table 6 Comparison of biochemistry characteristics between chronic hepatitis C patients with or without GBV-C infection at the 6-month follow-up

Group	n	A/G	ALT/IU·L-1	AST/IU·L-1	TBil/μmol·L-1
(1) HCV RNA(+)	11	1.76 ± 0.17	127.11 ± 82.12	41.13 ± 19.07	7.49 ± 5.82
GBV-C RNA(+)
(2) HCV RNA(+)	48	1.82 ± 0.20	71.62 ± 47.74	26.05 ± 12.49	7.97 ± 3.91
GBV-C RNA (-)
(3) HCV RNA (-)	8	1.60 ± 0.13	33.11 ± 8.08	22.97 ± 9.78	7.26 ± 4.25
GBV-C RNA(+)
(4) HCV RNA (-)	13	1.60 ± 0.14	30.74 ± 20.01	24.65 ± 11.84	7.65 ± 3.23
GBV-C RNA (-)

Significant difference (P < 0.05) was found both in ALT between group 1 and group 3, group 2 and group 4, and in AST between group 1 and group 4. No significant difference (P > 0.05) was found in other biochemistry characteristics among the 4 groups.